Rubicon Organics Reports Q3 2026 Financial Results
Globe Newswire•16/11/2026•07:00 ET
1
Key Highlights
- ➤Q3 net revenue $18.3 million, up 17% year over year
- ➤Q3 Adjusted EBITDA $1.4 million, down 17% year over year
- ➤Cascadia generated approximately $2.3 million in Q3 revenue
- ➤Pacifica year-to-date cultivation yields increased approximately 16% year over year
- ➤Combined annualized cultivation capacity targeted at approximately 20,000 kg by mid-2027
Expert Statements
Margaret Brodie, CEO of Rubicon Organics
“2026 has been about building the platform for Rubicon’s next stage of growth, adding incremental supply from Pacifica and Cascadia, bringing key processes in-house and expanding our access to global markets.”
Margaret Brodie, CEO of Rubicon Organics
“Demand for our premium products remains strong, and Cascadia is contributing meaningful revenue.”
Margaret Brodie, CEO of Rubicon Organics
“While ramping the facility to optimal performance has taken longer than anticipated, results from recent crops reinforce our confidence in achieving targeted yields by year end.”
Margaret Brodie, CEO of Rubicon Organics
“At Pacifica, yields have increased 16% year to date compared with the prior year, and successful lighting trials have demonstrated further opportunity to increase production.”
Margaret Brodie, CEO of Rubicon Organics
“We have now moved to the next phase of this project, installing upgraded lighting across all of Pacifica’s cultivation areas, with two compartments operationalized to date.”
Margaret Brodie, CEO of Rubicon Organics
“Our focus going forward is on translating this expanded platform into our financial results.”
Margaret Brodie, CEO of Rubicon Organics
“With additional cultivation capacity, a growing international business and continued investment in genetics, we believe Rubicon is well positioned to deliver sustainable long-term growth.”
Glen Ibbott, CFO of Rubicon Organics
“Q3 delivered solid net revenue growth and continued operating progress, with revenue of $18.3 million, up 17% year over year, and Adjusted EBITDA of $1.4 million.”
Glen Ibbott, CFO of Rubicon Organics
“International sales represented 11.7% of quarterly net revenue as that program continued to ramp.”
Glen Ibbott, CFO of Rubicon Organics
“And while margins continue to reflect the costs of scaling our expanded production platform, we are making strong progress on the initiatives expected to improve capacity, efficiency and financial performance as we move into 2027.”
* Q3 2026 net revenue of $18.3 million and year-to-date net revenue of $50.4 million, both up 17% year-over-year.
* Adjusted EBITDA(1) of $1.4 million for Q3 2026, compared to $1.7 million in Q3 2025, as the Company continues to absorb the costs of scaling Cascadia.
Get started
Create a free account to read the full story.
